References
- Reyntjens A, Verlinden M, Aerts T. Development and clinical use of the new gastrointestinal prokinetic drug cisapride (R51619). Drug Develop Res 1986; 8: 251–65
- Schuurkes J AJ, Van Bergen P JE, Van Nueten J M. Prejunctional muscarinic (M1)-receptor interactions on guinea pig ileum; lack of effect of cisapride. Br J Pharmacol 1988; 94: 228–34
- Gear M W, Barnes R J. Endoscopic studies of dyspepsia in general practice. Br Med J 1980; 280: 1136–7
- Non-ulcer dyspepsia. Lancet 1986; 1: 1306–7
- Richter J E. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991; 26: 11–6, Suppl 182
- Colin-Jones D G. Management of dyspepsia: report of a working group. Lancet 1988; 1: 576–9
- Rösch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987; 22: 161–4
- François I, de Nutte N. Nonulcer dyspepsia: effect of the gastrointestinal prokinetic drug cisapride. Curr Ther Res 1987; 41: 891–8
- Hannon R. Efficacy of cisapride in patients with nonulcer dyspepsia. Curr Ther Res 1987; 42: 814–22
- Goethals C, Van de Mierop L. Cisapride in the treatment of chronic function dyspepsia. Curr Ther Res 1987; 42: 261–7
- Nyrén O. Therapeutic trial in functional dyspepsia: its role in the primary care setting. Scand J Gastroenterol 1991; 26: 61–9, Suppl 182
- Nyrén O, Adami H O, Bates S. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–43
- Heatley R V, Rathbone B J. Dyspepsia: a dilemma for doctors. Lancet 1987; 2: 779–82